A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...

The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...

Lenacapavir, approved by the US FDA, presents a groundbreaking advancement in the battle against HIV. Developed by Gilead ...

With new treatments and maybe even a vaccine on the horizon, 2025 could be an important year for improving the lives of ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ...

The latest recommendations are presented for the treatment and prevention of HIV, including new antiretroviral therapies and long-acting injectable options.

Researchers analyzed 22 recent studies exploring HIV-related outcomes in the context of climate change and identified several links between extreme weather events and HIV prevention and care.

New challenges in HIV prevention and care are emerging due to climate change, according to a review published in Current ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication associated with bone marrow transplant, as well as a novel HIV drug that only ...